posted on 2025-04-15, 20:45authored byErlaitz
Basabe Obregón, Leire Villaescusa, José Trujillo-Sierra, Roberta Mastroddi, Karl Anker Jørgensen
Enantioselective
transformations of donor–acceptor cyclopropanes
have opened a new chemical space for the construction of enantioenriched
molecules. This work presents the first catalytic enantioselective
synthesis of isoxazolidinesa privileged key-structure in organic
and medicinal chemistrythrough a Brønsted-base catalyzed
(3 + 2) annulation of donor–acceptor cyclopropanes with nitrosoarenes.
The reaction concept is general, scalable to gram-scale, and enables
the reaction between cyclopropanes, substituted with ketones, aldehydes,
esters, thioesters, or sulfones, and nitrosoarenes with different
substitution patterns, yielding isoxazolidines in generally excellent
yields (up to 98%) and enantioselectivities (up to 97% ee). For the
(3 + 2) annulation of β-cyclopropyl ketones with nitrosobenzenes,
a Hammett study was conducted to elucidate the role of substituents
on enantioselectivity. The isoxazolidines can undergo different transformations,
such as oxidative cleavage of the N-PMP-group or
N–O bond cleavage by LiAlH4, where the two cyano
groups are key-functionalities, as this reaction also provided the
simultaneous didecyanation and reduction of the carbonyl, affording
attractive 5-amino-1,3-diols, a scaffold present in drugs like atorvastatin.
Finally, a mechanistic model is proposed to account for the stereochemical
outcome of the (3 + 2) annulation.